3 unknown. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Unknown 3 |
| Phase 1 | 2 | Unknown 2 |
Follow Corneal Ectasia: new trials by email Literature Review of Corneal Ectasia trials Research Report on Corneal Ectasia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Effectiveness of the PXL-Platinum 330 System PXL-330 Platinum device for crosslinking with Peschke riboflavin solution - Corneal Ectasia, Keratoconus | Phase 1 / Phase 2 | Unknown | Colorado Eye Consultants/Cornea Consultants of Colorado | 300 | 2020-06-01 | 2022-01-25 |
| Clinical and Structural Outcome of Conventional Versus Accelerated Corneal Collagen Cross-linking (CXL). UV-X 1000 (3 mW/cm²), UV-X 2000 (9 mW/cm²), riboflavin with hydroxypropyl methylcellulose - Keratoconus, Corneal Ectasia | Phase 1 / Phase 2 | Unknown | Oslo University Hospital | 40 | 2012-08-01 | 2016-08-30 |
| UVA-Riboflavin Crosslinking Treatment of Corneal Ectasia UV-X Light, Riboflavin - Keratoconus, Ectasia | Phase 2 | Unknown | Mercy Center for Corrective Eye Surgery | 250 | 2011-03-01 | 2011-03-29 |
Keratoconus (3) · Corneal Diseases (1) · Dilatation, Pathologic (1) · Eye Diseases (1)
Corneal Diseases (2) · Eye Diseases (2) · Pathological Conditions, Anatomical (1) · Pathological Conditions, Signs and Symptoms (1)
Riboflavin (2) · Corneal Cross-Linking (1) · Hypromellose Derivatives (1) · Radiation (1) · Radiotherapy (1)
Colorado Eye Consultants/Cornea Consultants of Colorado (1) · Mercy Center for Corrective Eye Surgery (1) · Oslo University Hospital (1)
United States (2)
Robert L Epstein, MD (1) · S. Lance Forstot, M.D. (1)
PMID 16765803, PMID 16952090, PMID 18471635, PMID 18811118, PMID 20138607, PMID 20164744